Download presentation
Presentation is loading. Please wait.
Published byAustin Owen Modified over 5 years ago
1
Refractive Cataract Surgery and Comanagement Implications
Scott O. Sykes, MD Utah Eye Centers Mount Ogden Eye Center
2
Refractive Cataract Surgery
Improving spherical equivalent outcomes Improving astigmatism outcomes Addressing Presbyopia Monovision Presbyopia IOLs Post refractive surgery patients Comanagement Preoperative issues Postoperative issues
3
Preoperative Comanagement Issues
Concurrent eye disease Glaucoma Pseudoexfoliation Macular health (ERM, AMD, etc) Corneal disease Prior refractive surgery Amblyopia Prior monovision (which eye, how myopic?) Psychological factors
4
Preoperative considerations: Glaucoma and PX
MIGS options: iStent Cypass—myopic shift possible Pupillary miosis: increased operative risk Zonular laxity: increased operative risk and postoperative decentration
5
Concomitant Cataract & Glaucoma Patients - US
Significant Treatment Opportunity One in five Cataracts Eyes on OHT Medication Centers for Medicare and Medicaid Services – Medicare Standard Analytical File. Baltimore, MD. 2007 . CONFIDENTIAL
6
Concurrent eye disease: Macular issues
Modern Cataract Surgery: Preop Macular OCT on every patient Macular Degeneration Epiretinal Membrane Diabetic Retinopathy Visual potential Multifocal IOLs Toric IOLs
7
Macular Issues
8
Concurrent eye disease: corneal disease
Keratoconus Keratopathy Dry Eye ABMD Nodular Degeneration Prior Refractive Surgery
9
Keratoconus/PMD Modern Cataract Surgery: preop topo on every patient, both eyes Form Fruste Keratoconus surprisingly common with routine preop topography testing Visual potential Refractive unpredictability Multifocal IOLs RGP tolerance and success Post operative expectations Future transplant risk Case Review (Rounds patient)
10
Case Review: PMD (previously undetected; patient an attorney )
11
Case Review: PMD (previously undetected; patient an attorney )
Preop extensive discussion of irregular astigmatism Two months post-op UCVA: 20/25 +2 OD, 20/20 OS +0.25 – 0.25 x /20 OD +0.25 – 0.25 x /20 OS
12
Other Corneal Issues: Keratopathy
Keratopathy: DES, ABMD, Scarring Visual potential Irregular astigmatism Refractive unpredictability Post operative expectations Preoperative treatments (delaying cataract surgery) Preoperative corneal surgery Case Review (ES)
13
Keratopathy: Case Review
14
Keratopathy: Case Review
Keratometry: Before Rx for DES: x (45.34) After Rx for DES: x (44.52) Refractive error avoided: 0.82 D hyperopia Post op UCVA: 20/20 Delay surgery as long as needed to get the cornea healthy and stable.
15
Preoperative astigmatism
Refractive astigmatism vs. corneal astigmatism Anterior corneal astigmatism vs. posterior corneal astigmatism Regular astigmatism vs. irregular astigmatism
16
Preoperative Astigmatism
52 year old man referred for cataract evaluation OD – 3.00 x /25 Mild NS and PSC OS unable to refract CF Severe NS and PSC How should we treat his astigmatism?
17
Refractive astigmatism vs. corneal astigmatism
18
Refractive astigmatism vs. corneal astigmatism
No astigmatism treatment Result: 20/20 OU UCVA
19
Astigmatism from Pterygium prior to Cataract Surgery
20
Nodular Degeneration or ABMD
22
Improving refractive predictability post refractive surgery
Clinical history method Advanced IOL formulas/calculators Intra operative abberometry (ORA)
23
IOL Formula: Old and New
Net corneal power (K) Ks, Kf, axis Axial length (AL) Piol: IOL Implant power Effective lens position (ELP) WTW Rfx: Desired post op refraction Vertex distance (V)
27
IOL Formula: Old and New
Net corneal power (K) Ks, Kf, axis Axial length (AL) Piol: IOL Implant power Effective lens position (ELP) WTW Rfx: Desired post op refraction Vertex distance (V)
28
All (Excluding Post lvC)
29
All Cases (Excluding Post lvC)
30
Symfony
31
Toric IOLs
32
Toric IOLs
33
Toric IOLs
34
ORA Influenced
35
Post Myopic LVC (All Surgeons)
36
Post Hyperopic LVC (All Surgeons)
37
Post RK (All Surgeons)
38
Intraoperative Aberrometry: Not an independent, stand-alone prediction
ORA recommendation still based on all formula variables Bad data in = bad data out Incorrect data (data entry errors, etc.) Inaccurate data Post refractive surgery Poor quality (dry eye, ABMD, etc) Intraoperative measurement variables (IOP, speculum pressure, fluid, corneal hydration, viscoelastic, etc.) Outliers are still outliers (AL, K’s, etc) ORA gives additional benefit of a wavefront-measured aphakic refraction and a proprietary modification of the formula.
39
Does ORA Help? Bottom Line
Outcome within 0.5 D of target ORA: 85% No ORA:75% How often do I make a change because of ORA? 1 of 3.5 patients How often does the change yield a better outcome? 3 of 4 patients What is the magnitude of the change? 0.25 D Is this worth the cost to the patient or the surgeon? Patient cost: bundled into premium package ($100) Surgeon cost: Preop staff time Increased operative time Decreased postoperative chair time Decreased postoperative enhancement rate
40
Lessons Learned & Next Steps
ORA helpful, but still must consider as just one piece of information. Great outcomes analysis tool as well. Post-refractive surgery: ASCRS Post refractive Barrett formula surprisingly good but ORA helps some. Post operative data needs to be more reliable (e.g., tech refractions vs. MD/OD refractions). Upcoming comparison for second eye surgery: ORA vs. first eye outcome Upcoming comparison of Barrett Formula vs ORA. IOL Master 500 can’t calculate Barrett
41
Postoperative issues for comanagement
Refractive error Posterior capsule opacification (PCO) Anterior capsule phimosis Communicating results to ophthalmologist
42
Managing postoperative refractive error
Manage based on patient and physician expectations Was a premium lens used? Is the patient happy? Correcting postoperative refractive error Glasses LRI Lasik or PRK IOL exchange
43
Managing postoperative refractive error
Large spherical surprises: treat early (2-4 weeks) with IOL exchange Large astigmatic surprises after toric IOL: treat after at least two weeks with Toric IOL repositioning Mild refractive error Watch until stable, 3-4 months Treat with glasses, LRI, or PRK/LASIK
44
Cost of Touch Ups after Premium Technology Use
Usually covered in initial upgrade fee, so no additional fee for LRI or PRK/LASIK
45
Managing Posterior Capsule Opacification
Rule out other causes of reduced vision, especially CME or corneal causes Treat the patient, not the capsule Patients must be visually symptomatic Preferably YAG done after 3-4 months Don’t YAG if any concern about need for IOL exchange
46
Managing Postoperative Cystoid Macular Edema
Topical Steroid and NSAID Follow with serial OCT Retina consult if not resolving
47
Anterior Capsule Phimosis
48
Managing postoperative anterior capsule phimosis
Usually in pseudoexfoliation May not be evident until late without dilated examination Causes hyperopic shift usually Increases risk of zonular weakening and lens decentration Refer for YAG as soon as recognized Case Review
49
Communicating postoperative results
Satisfies legal requirements Leads to better outcomes by providing data for nomograms
50
Thank You
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.